+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Compounding Pharmacy Market 2024-2028

  • PDF Icon

    Report

  • 168 Pages
  • July 2024
  • Region: Global
  • TechNavio
  • ID: 5681530
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The compounding pharmacy market is forecasted to grow by USD 1.63 billion during 2023-2028, accelerating at a CAGR of 2.09% during the forecast period. The report on the compounding pharmacy market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing popularity of hrt fueling demand for compounded medications, increasing prevalence of hormonal imbalance problems, and government regulations and initiatives.

The compounding pharmacy market is segmented as below:

By Product

  • Topical medications
  • Oral medications
  • Parenteral medications
  • Others

By Therapeutic Area

  • Pain management
  • Hormone replacement
  • Dermal disorders
  • Others

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the rising popularity of personalized medicines as one of the prime reasons driving the compounding pharmacy market growth during the next few years. Also, untapped opportunities in emerging markets and global shortage of essential drugs will lead to sizable demand in the market.

The report on the compounding pharmacy market covers the following areas:

  • Compounding pharmacy market sizing
  • Compounding pharmacy market forecast
  • Compounding pharmacy market industry analysis
A robust vendor analysis within the report is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading compounding pharmacy market vendors that include ACPHARM QUEENSLAND Pty Ltd., Advance Pharmacy, Athenex Inc., B.Braun SE, Doughertys Pharmacy, Fagron NV, Fresenius SE and Co. KGaA, Institutional Pharmacy Solutions, ITC Compounding Pharmacy, Lee Silsby Compounding Pharmacy, McGuff Co. Inc., Nephron Pharmaceuticals Corp., Olympia Pharmacy, PenCol Specialty Pharmacy, QuVa Pharma Inc., Rx3 Compounding Pharmacy, Triangle Compounding Pharmacy, Valor Compounding Pharmacy, Village Compounding Pharmacy, and Wedgewood Village Pharmacy LLC. Also, the compounding pharmacy market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Product
Executive Summary - Chart on Market Segmentation by Therapeutic Area
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Market Landscape
2.1 Market ecosystem
Parent Market
Data Table on - Parent Market
2.2 Market characteristics
Market characteristics analysis
2.3 Value chain analysis
Value Chain Analysis
3 Market Sizing
3.1 Market definition
Offerings of companies included in the market definition
3.2 Market segment analysis
Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Chart on Global - Market size and forecast 2023-2028 ($ million)
Data Table on Global - Market size and forecast 2023-2028 ($ million)
Chart on Global Market: Year-over-year growth 2023-2028 (%)
Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global Compounding Pharmacy Market 2018 - 2022
Historic Market Size - Data Table on Global Compounding Pharmacy Market 2018 - 2022 ($ million)
4.2 Product segment analysis 2018 - 2022
Historic Market Size - Product Segment 2018 - 2022 ($ million)
4.3 Therapeutic Area segment analysis 2018 - 2022
Historic Market Size - Therapeutic Area Segment 2018 - 2022 ($ million)
4.4 Geography segment analysis 2018 - 2022
Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country segment analysis 2018 - 2022
Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Product
6.1 Market segments
Chart on Product - Market share 2023-2028 (%)
Data Table on Product - Market share 2023-2028 (%)
6.2 Comparison by Product
Chart on Comparison by Product
Data Table on Comparison by Product
6.3 Topical medications - Market size and forecast 2023-2028
Chart on Topical medications - Market size and forecast 2023-2028 ($ million)
Data Table on Topical medications - Market size and forecast 2023-2028 ($ million)
Chart on Topical medications - Year-over-year growth 2023-2028 (%)
Data Table on Topical medications - Year-over-year growth 2023-2028 (%)
6.4 Oral medications - Market size and forecast 2023-2028
Chart on Oral medications - Market size and forecast 2023-2028 ($ million)
Data Table on Oral medications - Market size and forecast 2023-2028 ($ million)
Chart on Oral medications - Year-over-year growth 2023-2028 (%)
Data Table on Oral medications - Year-over-year growth 2023-2028 (%)
6.5 Parenteral medications - Market size and forecast 2023-2028
Chart on Parenteral medications - Market size and forecast 2023-2028 ($ million)
Data Table on Parenteral medications - Market size and forecast 2023-2028 ($ million)
Chart on Parenteral medications - Year-over-year growth 2023-2028 (%)
Data Table on Parenteral medications - Year-over-year growth 2023-2028 (%)
6.6 Others - Market size and forecast 2023-2028
Chart on Others - Market size and forecast 2023-2028 ($ million)
Data Table on Others - Market size and forecast 2023-2028 ($ million)
Chart on Others - Year-over-year growth 2023-2028 (%)
Data Table on Others - Year-over-year growth 2023-2028 (%)
6.7 Market opportunity by Product
Market opportunity by Product ($ million)
Data Table on Market opportunity by Product ($ million)
7 Market Segmentation by Therapeutic Area
7.1 Market segments
Chart on Therapeutic Area - Market share 2023-2028 (%)
Data Table on Therapeutic Area - Market share 2023-2028 (%)
7.2 Comparison by Therapeutic Area
Chart on Comparison by Therapeutic Area
Data Table on Comparison by Therapeutic Area
7.3 Pain management - Market size and forecast 2023-2028
Chart on Pain management - Market size and forecast 2023-2028 ($ million)
Data Table on Pain management - Market size and forecast 2023-2028 ($ million)
Chart on Pain management - Year-over-year growth 2023-2028 (%)
Data Table on Pain management - Year-over-year growth 2023-2028 (%)
7.4 Hormone replacement - Market size and forecast 2023-2028
Chart on Hormone replacement - Market size and forecast 2023-2028 ($ million)
Data Table on Hormone replacement - Market size and forecast 2023-2028 ($ million)
Chart on Hormone replacement - Year-over-year growth 2023-2028 (%)
Data Table on Hormone replacement - Year-over-year growth 2023-2028 (%)
7.5 Dermal disorders - Market size and forecast 2023-2028
Chart on Dermal disorders - Market size and forecast 2023-2028 ($ million)
Data Table on Dermal disorders - Market size and forecast 2023-2028 ($ million)
Chart on Dermal disorders - Year-over-year growth 2023-2028 (%)
Data Table on Dermal disorders - Year-over-year growth 2023-2028 (%)
7.6 Others - Market size and forecast 2023-2028
Chart on Others - Market size and forecast 2023-2028 ($ million)
Data Table on Others - Market size and forecast 2023-2028 ($ million)
Chart on Others - Year-over-year growth 2023-2028 (%)
Data Table on Others - Year-over-year growth 2023-2028 (%)
7.7 Market opportunity by Therapeutic Area
Market opportunity by Therapeutic Area ($ million)
Data Table on Market opportunity by Therapeutic Area ($ million)
8 Customer Landscape
8.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2023-2028 (%)
Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Chart on North America - Market size and forecast 2023-2028 ($ million)
Data Table on North America - Market size and forecast 2023-2028 ($ million)
Chart on North America - Year-over-year growth 2023-2028 (%)
Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Chart on Europe - Market size and forecast 2023-2028 ($ million)
Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Chart on Europe - Year-over-year growth 2023-2028 (%)
Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Chart on Asia - Market size and forecast 2023-2028 ($ million)
Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Chart on Asia - Year-over-year growth 2023-2028 (%)
Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Chart on US - Market size and forecast 2023-2028 ($ million)
Data Table on US - Market size and forecast 2023-2028 ($ million)
Chart on US - Year-over-year growth 2023-2028 (%)
Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Canada - Market size and forecast 2023-2028
Chart on Canada - Market size and forecast 2023-2028 ($ million)
Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Chart on Canada - Year-over-year growth 2023-2028 (%)
Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.9 France - Market size and forecast 2023-2028
Chart on France - Market size and forecast 2023-2028 ($ million)
Data Table on France - Market size and forecast 2023-2028 ($ million)
Chart on France - Year-over-year growth 2023-2028 (%)
Data Table on France - Year-over-year growth 2023-2028 (%)
9.10 China - Market size and forecast 2023-2028
Chart on China - Market size and forecast 2023-2028 ($ million)
Data Table on China - Market size and forecast 2023-2028 ($ million)
Chart on China - Year-over-year growth 2023-2028 (%)
Data Table on China - Year-over-year growth 2023-2028 (%)
9.11 Japan - Market size and forecast 2023-2028
Chart on Japan - Market size and forecast 2023-2028 ($ million)
Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Chart on Japan - Year-over-year growth 2023-2028 (%)
Data Table on Japan - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ million)
Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Opportunity/Restraints
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Impact of drivers and challenges in 2023 and 2028
10.4 Market opportunities/restraints
11 Competitive Landscape
11.1 Overview
11.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
11.3 Landscape disruption
Overview on factors of disruption
11.4 Industry risks
Impact of key risks on business
12 Competitive Analysis
12.1 Companies profiled
Companies covered
12.2 Market positioning of companies
Matrix on companies position and classification
12.3 Advance Pharmacy
Advance Pharmacy - Overview
Advance Pharmacy - Product / Service
Advance Pharmacy - Key offerings
12.4 Athenex Inc.
Athenex Inc. - Overview
Athenex Inc. - Product / Service
Athenex Inc. - Key offerings
12.5 B.Braun SE
B.Braun SE - Overview
B.Braun SE - Business segments
B.Braun SE - Key news
B.Braun SE - Key offerings
B.Braun SE - Segment focus
12.6 Fagron NV
Fagron NV - Overview
Fagron NV - Business segments
Fagron NV - Key news
Fagron NV - Key offerings
Fagron NV - Segment focus
12.7 Fresenius SE and Co. KGaA
Fresenius SE and Co. KGaA - Overview
Fresenius SE and Co. KGaA - Business segments
Fresenius SE and Co. KGaA - Key news
Fresenius SE and Co. KGaA - Key offerings
Fresenius SE and Co. KGaA - Segment focus
12.8 Institutional Pharmacy Solutions
Institutional Pharmacy Solutions - Overview
Institutional Pharmacy Solutions - Product / Service
Institutional Pharmacy Solutions - Key offerings
12.9 ITC Compounding Pharmacy
ITC Compounding Pharmacy - Overview
ITC Compounding Pharmacy - Product / Service
ITC Compounding Pharmacy - Key offerings
12.10 McGuff Co. Inc.
McGuff Co. Inc. - Overview
McGuff Co. Inc. - Product / Service
McGuff Co. Inc. - Key offerings
12.11 Nephron Pharmaceuticals Corp.
Nephron Pharmaceuticals Corp. - Overview
Nephron Pharmaceuticals Corp. - Product / Service
Nephron Pharmaceuticals Corp. - Key offerings
12.12 Olympia Pharmacy
Olympia Pharmacy - Overview
Olympia Pharmacy - Product / Service
Olympia Pharmacy - Key offerings
12.13 PenCol Specialty Pharmacy
PenCol Specialty Pharmacy - Overview
PenCol Specialty Pharmacy - Product / Service
PenCol Specialty Pharmacy - Key offerings
12.14 Rx3 Compounding Pharmacy
Rx3 Compounding Pharmacy - Overview
Rx3 Compounding Pharmacy - Product / Service
Rx3 Compounding Pharmacy - Key offerings
12.15 Triangle Compounding Pharmacy
Triangle Compounding Pharmacy - Overview
Triangle Compounding Pharmacy - Product / Service
Triangle Compounding Pharmacy - Key offerings
12.16 Valor Compounding Pharmacy
Valor Compounding Pharmacy - Overview
Valor Compounding Pharmacy - Product / Service
Valor Compounding Pharmacy - Key offerings
12.17 Wedgewood Village Pharmacy LLC
Wedgewood Village Pharmacy LLC - Overview
Wedgewood Village Pharmacy LLC - Product / Service
Wedgewood Village Pharmacy LLC - Key offerings
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
13.3 Currency conversion rates for US$
Currency conversion rates for US$
13.4 Research methodology
Research methodology
13.5 Data procurement
Information sources
13.6 Data validation
Data validation
13.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
13.8 Data synthesis
Data synthesis
13.9 360 degree market analysis
360 degree market analysis
13.10 List of abbreviations
List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Product
Exhibits 6: Executive Summary - Chart on Market Segmentation by Therapeutic Area
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Company Market Positioning
Exhibits 10: Parent Market
Exhibits 11: Data Table on - Parent Market
Exhibits 12: Market characteristics analysis
Exhibits 13: Value Chain Analysis
Exhibits 14: Offerings of companies included in the market definition
Exhibits 15: Market segments
Exhibits 16: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 17: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 18: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 19: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 20: Historic Market Size - Data Table on Global Compounding Pharmacy Market 2018 - 2022 ($ million)
Exhibits 21: Historic Market Size - Product Segment 2018 - 2022 ($ million)
Exhibits 22: Historic Market Size - Therapeutic Area Segment 2018 - 2022 ($ million)
Exhibits 23: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits 24: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits 25: Five forces analysis - Comparison between 2023 and 2028
Exhibits 26: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits 27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits 28: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits 29: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits 30: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits 31: Chart on Market condition - Five forces 2023 and 2028
Exhibits 32: Chart on Product - Market share 2023-2028 (%)
Exhibits 33: Data Table on Product - Market share 2023-2028 (%)
Exhibits 34: Chart on Comparison by Product
Exhibits 35: Data Table on Comparison by Product
Exhibits 36: Chart on Topical medications - Market size and forecast 2023-2028 ($ million)
Exhibits 37: Data Table on Topical medications - Market size and forecast 2023-2028 ($ million)
Exhibits 38: Chart on Topical medications - Year-over-year growth 2023-2028 (%)
Exhibits 39: Data Table on Topical medications - Year-over-year growth 2023-2028 (%)
Exhibits 40: Chart on Oral medications - Market size and forecast 2023-2028 ($ million)
Exhibits 41: Data Table on Oral medications - Market size and forecast 2023-2028 ($ million)
Exhibits 42: Chart on Oral medications - Year-over-year growth 2023-2028 (%)
Exhibits 43: Data Table on Oral medications - Year-over-year growth 2023-2028 (%)
Exhibits 44: Chart on Parenteral medications - Market size and forecast 2023-2028 ($ million)
Exhibits 45: Data Table on Parenteral medications - Market size and forecast 2023-2028 ($ million)
Exhibits 46: Chart on Parenteral medications - Year-over-year growth 2023-2028 (%)
Exhibits 47: Data Table on Parenteral medications - Year-over-year growth 2023-2028 (%)
Exhibits 48: Chart on Others - Market size and forecast 2023-2028 ($ million)
Exhibits 49: Data Table on Others - Market size and forecast 2023-2028 ($ million)
Exhibits 50: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits 51: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits 52: Market opportunity by Product ($ million)
Exhibits 53: Data Table on Market opportunity by Product ($ million)
Exhibits 54: Chart on Therapeutic Area - Market share 2023-2028 (%)
Exhibits 55: Data Table on Therapeutic Area - Market share 2023-2028 (%)
Exhibits 56: Chart on Comparison by Therapeutic Area
Exhibits 57: Data Table on Comparison by Therapeutic Area
Exhibits 58: Chart on Pain management - Market size and forecast 2023-2028 ($ million)
Exhibits 59: Data Table on Pain management - Market size and forecast 2023-2028 ($ million)
Exhibits 60: Chart on Pain management - Year-over-year growth 2023-2028 (%)
Exhibits 61: Data Table on Pain management - Year-over-year growth 2023-2028 (%)
Exhibits 62: Chart on Hormone replacement - Market size and forecast 2023-2028 ($ million)
Exhibits 63: Data Table on Hormone replacement - Market size and forecast 2023-2028 ($ million)
Exhibits 64: Chart on Hormone replacement - Year-over-year growth 2023-2028 (%)
Exhibits 65: Data Table on Hormone replacement - Year-over-year growth 2023-2028 (%)
Exhibits 66: Chart on Dermal disorders - Market size and forecast 2023-2028 ($ million)
Exhibits 67: Data Table on Dermal disorders - Market size and forecast 2023-2028 ($ million)
Exhibits 68: Chart on Dermal disorders - Year-over-year growth 2023-2028 (%)
Exhibits 69: Data Table on Dermal disorders - Year-over-year growth 2023-2028 (%)
Exhibits 70: Chart on Others - Market size and forecast 2023-2028 ($ million)
Exhibits 71: Data Table on Others - Market size and forecast 2023-2028 ($ million)
Exhibits 72: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits 73: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits 74: Market opportunity by Therapeutic Area ($ million)
Exhibits 75: Data Table on Market opportunity by Therapeutic Area ($ million)
Exhibits 76: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 77: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 78: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 79: Chart on Geographic comparison
Exhibits 80: Data Table on Geographic comparison
Exhibits 81: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 82: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 83: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits 84: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits 85: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 86: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 87: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 88: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 89: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 90: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 91: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 92: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 93: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 94: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 95: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 96: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 97: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits 98: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits 99: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits 100: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits 101: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits 102: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits 103: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits 104: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits 105: Chart on France - Market size and forecast 2023-2028 ($ million)
Exhibits 106: Data Table on France - Market size and forecast 2023-2028 ($ million)
Exhibits 107: Chart on France - Year-over-year growth 2023-2028 (%)
Exhibits 108: Data Table on France - Year-over-year growth 2023-2028 (%)
Exhibits 109: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits 110: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits 111: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits 112: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits 113: Chart on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits 114: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits 115: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibits 116: Data Table on Japan - Year-over-year growth 2023-2028 (%)
Exhibits 117: Market opportunity By Geographical Landscape ($ million)
Exhibits 118: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits 119: Impact of drivers and challenges in 2023 and 2028
Exhibits 120: Overview on criticality of inputs and factors of differentiation
Exhibits 121: Overview on factors of disruption
Exhibits 122: Impact of key risks on business
Exhibits 123: Companies covered
Exhibits 124: Matrix on companies position and classification
Exhibits 125: Advance Pharmacy - Overview
Exhibits 126: Advance Pharmacy - Product / Service
Exhibits 127: Advance Pharmacy - Key offerings
Exhibits 128: Athenex Inc. - Overview
Exhibits 129: Athenex Inc. - Product / Service
Exhibits 130: Athenex Inc. - Key offerings
Exhibits 131: B.Braun SE - Overview
Exhibits 132: B.Braun SE - Business segments
Exhibits 133: B.Braun SE - Key news
Exhibits 134: B.Braun SE - Key offerings
Exhibits 135: B.Braun SE - Segment focus
Exhibits 136: Fagron NV - Overview
Exhibits 137: Fagron NV - Business segments
Exhibits 138: Fagron NV - Key news
Exhibits 139: Fagron NV - Key offerings
Exhibits 140: Fagron NV - Segment focus
Exhibits 141: Fresenius SE and Co. KGaA - Overview
Exhibits 142: Fresenius SE and Co. KGaA - Business segments
Exhibits 143: Fresenius SE and Co. KGaA - Key news
Exhibits 144: Fresenius SE and Co. KGaA - Key offerings
Exhibits 145: Fresenius SE and Co. KGaA - Segment focus
Exhibits 146: Institutional Pharmacy Solutions - Overview
Exhibits 147: Institutional Pharmacy Solutions - Product / Service
Exhibits 148: Institutional Pharmacy Solutions - Key offerings
Exhibits 149: ITC Compounding Pharmacy - Overview
Exhibits 150: ITC Compounding Pharmacy - Product / Service
Exhibits 151: ITC Compounding Pharmacy - Key offerings
Exhibits 152: McGuff Co. Inc. - Overview
Exhibits 153: McGuff Co. Inc. - Product / Service
Exhibits 154: McGuff Co. Inc. - Key offerings
Exhibits 155: Nephron Pharmaceuticals Corp. - Overview
Exhibits 156: Nephron Pharmaceuticals Corp. - Product / Service
Exhibits 157: Nephron Pharmaceuticals Corp. - Key offerings
Exhibits 158: Olympia Pharmacy - Overview
Exhibits 159: Olympia Pharmacy - Product / Service
Exhibits 160: Olympia Pharmacy - Key offerings
Exhibits 161: PenCol Specialty Pharmacy - Overview
Exhibits 162: PenCol Specialty Pharmacy - Product / Service
Exhibits 163: PenCol Specialty Pharmacy - Key offerings
Exhibits 164: Rx3 Compounding Pharmacy - Overview
Exhibits 165: Rx3 Compounding Pharmacy - Product / Service
Exhibits 166: Rx3 Compounding Pharmacy - Key offerings
Exhibits 167: Triangle Compounding Pharmacy - Overview
Exhibits 168: Triangle Compounding Pharmacy - Product / Service
Exhibits 169: Triangle Compounding Pharmacy - Key offerings
Exhibits 170: Valor Compounding Pharmacy - Overview
Exhibits 171: Valor Compounding Pharmacy - Product / Service
Exhibits 172: Valor Compounding Pharmacy - Key offerings
Exhibits 173: Wedgewood Village Pharmacy LLC - Overview
Exhibits 174: Wedgewood Village Pharmacy LLC - Product / Service
Exhibits 175: Wedgewood Village Pharmacy LLC - Key offerings
Exhibits 176: Inclusions checklist
Exhibits 177: Exclusions checklist
Exhibits 178: Currency conversion rates for US$
Exhibits 179: Research methodology
Exhibits 180: Information sources
Exhibits 181: Data validation
Exhibits 182: Validation techniques employed for market sizing
Exhibits 183: Data synthesis
Exhibits 184: 360 degree market analysis
Exhibits 185: List of abbreviations

Executive Summary

The following companies are recognized as the key players in the global compounding pharmacy market: ACPHARM QUEENSLAND Pty Ltd., Advance Pharmacy, Athenex Inc., B.Braun SE, Doughertys Pharmacy, Fagron NV, Fresenius SE and Co. KGaA, Institutional Pharmacy Solutions, ITC Compounding Pharmacy, Lee Silsby Compounding Pharmacy, McGuff Co. Inc., Nephron Pharmaceuticals Corp., Olympia Pharmacy, PenCol Specialty Pharmacy, QuVa Pharma Inc., Rx3 Compounding Pharmacy, Triangle Compounding Pharmacy, Valor Compounding Pharmacy, Village Compounding Pharmacy, and Wedgewood Village Pharmacy LLC.

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is rising popularity of personalized medicines."

According to the report, one of the major drivers for this market is the growing popularity of hrt fueling demand for compounded medications.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • ACPHARM QUEENSLAND Pty Ltd.
  • Advance Pharmacy
  • Athenex Inc.
  • B.Braun SE
  • Doughertys Pharmacy
  • Fagron NV
  • Fresenius SE and Co. KGaA
  • Institutional Pharmacy Solutions
  • ITC Compounding Pharmacy
  • Lee Silsby Compounding Pharmacy
  • McGuff Co. Inc.
  • Nephron Pharmaceuticals Corp.
  • Olympia Pharmacy
  • PenCol Specialty Pharmacy
  • QuVa Pharma Inc.
  • Rx3 Compounding Pharmacy
  • Triangle Compounding Pharmacy
  • Valor Compounding Pharmacy
  • Village Compounding Pharmacy
  • Wedgewood Village Pharmacy LLC